APA (7th ed.) Citation

Garrido, D., Slavutsky, I., Riva, E., Peña, C., Schutz, N., Tarín-Arzaga, L., . . . Fantl, D. (2023). Survival analysis of transplant-eligible newly-diagnosed multiple myeloma patients harboring t(4;14), t(14;16), and/or del(17p) in the real-world setting. Current problems in cancer, 47(1), 100916. https://doi.org/10.1016/j.currproblcancer.2022.100916

Chicago Style (17th ed.) Citation

Garrido, David, et al. "Survival Analysis of Transplant-eligible Newly-diagnosed Multiple Myeloma Patients Harboring T(4;14), T(14;16), And/or Del(17p) in the Real-world Setting." Current Problems in Cancer 47, no. 1 (2023): 100916. https://doi.org/10.1016/j.currproblcancer.2022.100916.

MLA (9th ed.) Citation

Garrido, David, et al. "Survival Analysis of Transplant-eligible Newly-diagnosed Multiple Myeloma Patients Harboring T(4;14), T(14;16), And/or Del(17p) in the Real-world Setting." Current Problems in Cancer, vol. 47, no. 1, 2023, p. 100916, https://doi.org/10.1016/j.currproblcancer.2022.100916.